Form 4 holding
Director, 10%+ Owner
NeuroBo Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 101,459
- Estimated value
- $317,567
- Report date
- 27 Jul 2023
- Price
- $3.13
- Ownership
- Direct
Na Yeon Kim - Director, 10%+ Owner at MetaVia Inc.
Issuer-level insider activity
- Role
- Director, 10%+ Owner
- Issuer ticker
- MTVA on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Na Yeon Kim since 06 Oct 2025
Reported holdings for Na Yeon Kim in MetaVia Inc.
Form 4 holding
Director, 10%+ Owner
NeuroBo Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 96,351
- Estimated value
- $301,579
- Report date
- 27 Jul 2023
- Price
- $3.13
- Ownership
- Held by The E&Healthcare Investment Fund II
Form 4 holding
Director, 10%+ Owner
NeuroBo Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 62,159
- Estimated value
- $194,558
- Report date
- 27 Jul 2023
- Price
- $3.13
- Ownership
- Held by The E&Healthcare Investment Fund No. 7
Form 4 holding
Director, 10%+ Owner
NeuroBo Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 37,373
- Estimated value
- $116,977
- Report date
- 27 Jul 2023
- Price
- $3.13
- Ownership
- Held by The E&Healthcare Investment Fund No. 6
Form 4 holding
Director, 10%+ Owner
NeuroBo Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 4,671
- Estimated value
- $14,620
- Report date
- 27 Jul 2023
- Price
- $3.13
- Ownership
- Held by E&Investment Inc.
Transaction history for Na Yeon Kim in MetaVia Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.